Lakewood-Amedex Biotherapeutics Inc. - 8-K Filing

Lakewood-Amedex Biotherapeutics Inc. receives Nasdaq delisting notice due to bid price falling below $1.00 for 30 consecutive business days. (Items: 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, 9.01 Financial Statements and Exhibits)

3 articles from 1 source · updated

Coverage